PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

1779 Resources
1779 Resources
1779 Resources
    Date
  1. This fact sheet describes a PATH project in Vietnam that is focusing on testing a new formulation of a locally made rotavirus vaccine. PATH, Vietnam-based manufacturer POLYVAC (Center for Research and Production of Vaccines and Biologicals), and Vietnam’s National Institute of Hygiene and Epidemiology are conducting a Phase 3 bridging study to compare a second-generation formulation of POLYVAC’s new liquid rotavirus vaccine (ROTAVIN) with the currently licensed version (ROTAVIN-M1). Both contain the same rotavirus strain, but ROTAVIN is stored at 2-8°C, while ROTAVIN-M1 must be kept frozen. ROTAVIN would therefore be more compatible with the cold chain currently in place in Vietnam, allowing for easier storage and transport. In the future, it could also be more attractive for use in other low- to middle-income settings.
    Published: March 2019
    Type: Resource Page
  2. Subcutaneous DMPA (DMPA-SC, brand name Sayana® Press) is all-in-one injectable contraceptive that protects against pregnancy for three months. PATH regularly hosts webinars to share the latest evidence and experience from DMPA-SC research, introduction, and scale-up, including self-injection.For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.
    Published: March 2019
    Type: Resource Page
  3. This report outlines achievements from investment and incentives in health innovation and how the G20 and associated multilaterals are essential to addressing the pressing global health challenges of our time. It also highlights existing and new models for innovative and blended forms of financing that significantly supplement funds that are currently provided by the governments, the private sector and philanthropic organizations.
    Published: March 2019
    Type: Resource Page
  4. The Diarrhea Innovations Group (DIG) is a global network of innovators committed to reducing child mortality and morbidity from enteric and diarrheal diseases through the advancement of appropriate diagnostic and therapeutic technologies and approaches. It is a voluntary association of academic, nonprofit, public, and private members. The group aims to accelerate progress by focusing on solutions with the greatest potential for positive health impact in countries that bear the highest disease burden.
    Published: February 2019
    Type: Resource Page
  5. Thousands of women are now taking charge of their reproductive health through self-injection of the contraceptive subcutaneous DMPA (DMPA-SC, brand name Sayana® Press). In this February 13, 2019 webinar, speakers presented evidence from five countries at different stages of DMPA-SC introduction and scale-up, from earliest (Ghana) to more advanced (Uganda). Speakers also shared insights on applying research findings to program design and delivery. This webinar was hosted by the DMPA-SC Access Collaborative Learning and Action Network.For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.
    Published: February 2019
    Type: Resource Page
Load more